SHLOMO PASCAL: Open Payments
NPI 1124171616 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 82 payments from 13 companies in 2025. Trend: 2023 $1,349 · 2024 $2,706 · 2025 $2,129
Food & beverage: $2,017Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $444 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $322 |
| Otsuka America Pharmaceutical, Inc. | 14 | $280 |
| Janssen Pharmaceuticals, Inc | 13 | $264 |
| E.R. Squibb & Sons, L.L.C. | 5 | $229 |
| Axsome Therapeutics, Inc. | 5 | $205 |
| Alkermes, Inc. | 9 | $149 |
| ABBVIE INC. | 3 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, Auvelity, ABILIFY ASIMTUFII, ARISTADA, UZEDY.
Industry payments across FL — which companies pay providers there.
